# An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))

> **NCT00568178** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 306 (actual)

## Conditions studied

- Proteinuria

## Interventions

- **DRUG:** Losartan Potassium
- **OTHER:** Comparator: Placebo (Losartan)
- **DRUG:** Comparator: amlodipine besylate
- **OTHER:** Comparator: Placebo (amlodipine besylate)
- **OTHER:** Placebo (Losartan)
- **DRUG:** Enalapril Maleate

## Key facts

- **NCT ID:** NCT00568178
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06-01
- **Primary completion:** 2008-09-01
- **Final completion:** 2011-03-01
- **Target enrollment:** 306 (ACTUAL)
- **Last updated:** 2024-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00568178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00568178, "An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00568178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*